The value of drug repositioning in the current pharmaceutical market.
@article{Tobinick2009TheVO,
title={The value of drug repositioning in the current pharmaceutical market.},
author={Edward Lewis Tobinick},
journal={Drug news \& perspectives},
year={2009},
volume={22 2},
pages={
119-25
}
}Drug repositioning is the process of developing new indications for existing drugs or biologics. Increasing interest in drug repositioning has occurred due to sustained high failure rates and costs involved in attempts to bring new drugs to market. It has been estimated that it may cost more than USD 800 million to develop a new drug de novo. In addition, due to regulatory requirements regarding safety, efficacy and quality, the time required to develop a new drug de novo has been estimated to…
Topics from this paper
190 Citations
Novel insight into drug repositioning: Methylthiouracil as a case in point.
- BiologyPharmacological research
- 2015
repositioning drugs and biologics: retargeting old/existing drugs for potential new therapeutic applications
- Biology, Medicine
- 2013
Experts are of the opinion that repositioning drug technology will have better integration in Pharma research for the next decade as several phases common to de novo drug discovery and development can be bypassed as compared with traditional discovery.
DRUG REPOSITIONING: AN OVERVIEW AND CLINICAL PERSPECTIVE
- Medicine, Biology
- 2020
This article focuses on drug pharmacology, pharmacodynamic, and safety profiles that are already known, undoubtedly allowing diagnostic studies to predominate.
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
- MedicineJournal of market access & health policy
- 2013
A harmonized nomenclature for drug repositioning, reformulation, and combination cases will allow for a robust analysis of the added value and market access conditions attributed for each strategy and case type as assessed by regulators and payors in Europe and the United States.
Challenges and opportunities of drug repositioning.
- BiologyTrends in pharmacological sciences
- 2013
Drug repositioning for personalized medicine
- Biology, ChemistryGenome Medicine
- 2012
The current state of research in personalized medicine and repositioning is discussed, focusing on recent large-scale efforts to systematically find repositioned candidates and elucidate individual disease mechanisms in cancer.
Drug Repositioning: A Faster Path to Drug Discovery
- Medicine
- 2012
Successfully repositioned drugs such as Viagra have hit the market with exponential pharmaceutical revenue records made at a fraction of the cost versus de novo methodologies paving the way for drug prospects that follow in similar footsteps.
New sources of drugs for hematologic malignancies.
- Biology, MedicineBlood
- 2011
Several scientific approaches used to identify drug repurposing opportunities are highlighted, with a focus on hematologic malignancies, and a discussion of the regulatory issues that are unique to drugRepurposing are included.
A New Therapeutic Applications for Drug Repositioning on the Cloud Computing
- Biology
- 2015
Converter can be bypassed when compared to traditional drug discovery, drug discovery and development, common in many phases of de novo cost, risk and time - reduced has many advantages.